$CHTH
CNL Healthcare Properties, Inc.

2013 Q2 Form 10-Q Financial Statement

#000119312513219527 Filed on May 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $8.609M $7.802M $941.0K
YoY Change 347.92% 729.12%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $604.0K $609.0K $385.1K
YoY Change 48.28% 58.13%
Operating Profit -$2.302M -$866.0K -$1.739M
YoY Change 481.31% -50.2%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$497.0K -$2.956M -$674.7K
YoY Change -67.35% 338.1%
Pretax Income -$2.799M -$3.822M -$2.413M
YoY Change 148.56% 58.37%
Income Tax $31.00K -$13.00K
% Of Pretax Income
Net Earnings -$2.830M -$3.809M -$2.413M
YoY Change 151.33% 57.85%
Net Earnings / Revenue -32.87% -48.82% -256.43%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 29.02M shares 24.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $9.279M $6.548M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $466.5M $339.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $179.0M $138.2M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$19.12M -$16.29M
YoY Change
Common Stock $365.6K $259.9K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $287.5M $452.0M $140.7M
YoY Change
Total Liabilities & Shareholders Equity $466.5M $339.2M
YoY Change

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$2.830M -$3.809M -$2.413M
YoY Change 151.33% 57.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $212.0K -$1.954M
YoY Change -110.85%
INVESTING ACTIVITIES
Capital Expenditures $83.65M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $7.683K
YoY Change
Cash From Investing Activities -$9.316M -$89.30M
YoY Change -89.57%
FINANCING ACTIVITIES
Cash Dividend Paid $987.0K $90.30K
YoY Change 992.99%
Common Stock Issuance & Retirement, Net -$72.61M $27.59M
YoY Change -363.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.621M 86.37M
YoY Change -94.65%
NET CHANGE
Cash From Operating Activities 212.0K -1.954M
Cash From Investing Activities -9.316M -89.30M
Cash From Financing Activities 4.621M 86.37M
Net Change In Cash -4.483M -4.887M
YoY Change -8.27%
FREE CASH FLOW
Cash From Operating Activities $212.0K -$1.954M
Capital Expenditures $83.65M
Free Cash Flow -$85.60M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29022274 shares
CY2011Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2011Q2 ck0001496454 Equity Issuance Dollar Amount Pursuant To Distribution Reinvestment Plan Per Share
EquityIssuanceDollarAmountPursuantToDistributionReinvestmentPlanPerShare
9.50
CY2012Q1 us-gaap Cash
Cash
5114930
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
31517776
CY2013Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
44697
CY2013Q1 us-gaap Derivative Forward Interest Rate
DerivativeForwardInterestRate
0.03935 pure
CY2013Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
172916
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2225789
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
200970704
CY2013Q1 us-gaap Other Assets
OtherAssets
3893902
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3362761
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000 shares
CY2013Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000 shares
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
644339
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25988429 shares
CY2013Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
535744
CY2013Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
100000
CY2013Q1 us-gaap Liabilities
Liabilities
138238220
CY2013Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2605682
CY2013Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
94855
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16289686
CY2013Q1 us-gaap Assets
Assets
339208924
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
339208924
CY2013Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
134004717
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
134004717
CY2013Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
228635110
CY2013Q1 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
70605404
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26013043 shares
CY2013Q1 us-gaap Derivative Basis Spread On Variable Rate
DerivativeBasisSpreadOnVariableRate
0.026 pure
CY2013Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
134000000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6548488
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2128316
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80412
CY2013Q1 us-gaap Cash
Cash
13778609
CY2013Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3697759
CY2013Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
1261149
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
259876
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2327671
CY2013Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
3800000
CY2013Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122758
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
92442404
CY2013Q1 us-gaap Development In Process
DevelopmentInProcess
11236241
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
222433252
CY2013Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
5352326
CY2013Q1 ck0001496454 Excess Stock
ExcessStock
CY2013Q1 ck0001496454 Preferred Stock Shares Unissued
PreferredStockSharesUnissued
200000000 shares
CY2013Q1 ck0001496454 Debt Instrument Maturity Month And Year
DebtInstrumentMaturityMonthAndYear
2013-06
CY2013Q1 ck0001496454 Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2013Q1 ck0001496454 Date Of Terminating Initial Offering
DateOfTerminatingInitialOffering
2014-06-27
CY2013Q1 ck0001496454 Excess Stock Shares Unissued
ExcessStockSharesUnissued
300000000 shares
CY2013Q1 ck0001496454 Marketing And Supporting Fees Due
MarketingAndSupportingFeesDue
140477
CY2013Q1 ck0001496454 Proceeds From Public Offering
ProceedsFromPublicOffering
255500000
CY2013Q1 ck0001496454 Selling Commissions Due
SellingCommissionsDue
90956
CY2013Q1 ck0001496454 Stock Issued On Period Shares New Issues
StockIssuedOnPeriodSharesNewIssues
25900000 shares
CY2013Q1 ck0001496454 Due To Related Party Fees And Commissions
DueToRelatedPartyFeesAndCommissions
231433
CY2013Q1 ck0001496454 Due To Related Party Reimbursable Costs Current And Noncurrent
DueToRelatedPartyReimbursableCostsCurrentAndNoncurrent
169373
CY2013Q1 ck0001496454 Due To Related Party Reimbursable Offering Costs
DueToRelatedPartyReimbursableOfferingCosts
112980
CY2013Q1 ck0001496454 Due To Related Party Reimbursable Operating Expenses
DueToRelatedPartyReimbursableOperatingExpenses
56393
CY2013Q1 ck0001496454 Business Acquisition Number Of Properties Purchase
BusinessAcquisitionNumberOfPropertiesPurchase
5 Property
CY2013Q1 ck0001496454 Total Real Estate Investment Property Net
TotalRealEstateInvestmentPropertyNet
239871351
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
9702387
CY2011Q4 us-gaap Cash
Cash
10001872
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
140650832
CY2012Q4 us-gaap Other Assets
OtherAssets
4266928
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000 shares
CY2012Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
609908
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18446504 shares
CY2012Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1289880
CY2012Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
100000
CY2012Q4 us-gaap Liabilities
Liabilities
197126471
CY2012Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3338286
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12480338
CY2012Q4 us-gaap Assets
Assets
337777303
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337777303
CY2012Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
193151591
CY2012Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
230410959
CY2012Q4 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
64560061
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18447553 shares
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
193200000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7024470
CY2012Q4 us-gaap Cash
Cash
18261750
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2685000
CY2012Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
843370
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
184467
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2000000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Development In Process
DevelopmentInProcess
8461571
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156199995
CY2012Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
3253292
CY2012Q4 ck0001496454 Excess Stock
ExcessStock
CY2012Q4 ck0001496454 Preferred Stock Shares Unissued
PreferredStockSharesUnissued
200000000 shares
CY2012Q4 ck0001496454 Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2012Q4 ck0001496454 Excess Stock Shares Unissued
ExcessStockSharesUnissued
300000000 shares
CY2012Q4 ck0001496454 Marketing And Supporting Fees Due
MarketingAndSupportingFeesDue
136337
CY2012Q4 ck0001496454 Proceeds From Public Offering
ProceedsFromPublicOffering
168100000
CY2012Q4 ck0001496454 Selling Commissions Due
SellingCommissionsDue
102656
CY2012Q4 ck0001496454 Stock Issued On Period Shares New Issues
StockIssuedOnPeriodSharesNewIssues
16900000 shares
CY2012Q4 ck0001496454 Due To Related Party Fees And Commissions
DueToRelatedPartyFeesAndCommissions
238993
CY2012Q4 ck0001496454 Due To Related Party Reimbursable Costs Current And Noncurrent
DueToRelatedPartyReimbursableCostsCurrentAndNoncurrent
598756
CY2012Q4 ck0001496454 Due To Related Party Reimbursable Offering Costs
DueToRelatedPartyReimbursableOfferingCosts
356463
CY2012Q4 ck0001496454 Due To Related Party Reimbursable Operating Expenses
DueToRelatedPartyReimbursableOperatingExpenses
242293
CY2012Q4 ck0001496454 Total Real Estate Investment Property Net
TotalRealEstateInvestmentPropertyNet
238872530
CY2012Q1 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
603303 shares
CY2012Q4 us-gaap Equity Method Investment Net Sales Proceeds
EquityMethodInvestmentNetSalesProceeds
62500000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14133
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-25450
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
13312
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-5935
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
168266307
CY2012 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3197400
CY2012 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
10474
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
821
CY2012 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39996
CY2012 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
23389230
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-10720758
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17252
CY2012 ck0001496454 Deferred Income Taxes Expense Benefit
DeferredIncomeTaxesExpenseBenefit
-31385
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
CNL Healthcare Properties, Inc.
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-06-08
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001496454
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
1849728
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
8667767
CY2013Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Reclassifications</i></b> &#x2014; Certain prior period amounts in the unaudited condensed consolidated financial statements have been reclassified to conform to the current period presentation with no effect on previously reported total assets and total liabilities, net loss or stockholders&#x2019; equity.</font></p> </div>
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-80412
CY2013Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
900000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-865642
CY2013Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
3217083
CY2013Q1 us-gaap Asset Management Costs
AssetManagementCosts
988620
CY2013Q1 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
22999
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
72831193
CY2013Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
7364402
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3889760
CY2013Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1337931
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
13503358
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.3535 pure
CY2013Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
34431
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
67085
CY2013Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13312
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-06-30
CY2013Q1 us-gaap Distribution Made To Member Or Limited Partner Cash Distributions Declared
DistributionMadeToMemberOrLimitedPartnerCashDistributionsDeclared
1657390
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
219151
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2318917
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0035 pure
CY2013Q1 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
80412
CY2013Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
578526
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
211742
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
3473084
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9315646
CY2013Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1130710
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-80412
CY2013Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-2100000
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73942926
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4483141
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1109032
CY2013Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
3484407
CY2013Q1 us-gaap Health Care Organization Resident Service Revenue
HealthCareOrganizationResidentServiceRevenue
4317718
CY2013Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2099034
CY2013Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1135
CY2013Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
219151
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4620763
CY2013Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
3236536
CY2013Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
301382
CY2013Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
165952
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
608550
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.3500 pure
CY2013Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7666152
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
278383
CY2013Q1 us-gaap Revenues
Revenues
7802125
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39996
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3822660
CY2013Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1574
CY2013Q1 us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
19700000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
7415109
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-891980
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22399106 shares
CY2013Q1 us-gaap Asset Management Fees
AssetManagementFees
10000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-3809348
CY2013Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
26272379
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2957018
CY2013Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1351243
CY2013Q1 us-gaap Owned Property Management Costs
OwnedPropertyManagementCosts
455589
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13312
CY2013Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
987301
CY2013Q1 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
811585
CY2013Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
85419253
CY2013Q1 ck0001496454 Offering Costs
OfferingCosts
203035
CY2013Q1 ck0001496454 Fees And Commission Expenses
FeesAndCommissionExpenses
7212074
CY2013Q1 ck0001496454 Deferred Income Taxes Expense Benefit
DeferredIncomeTaxesExpenseBenefit
-13312
CY2013Q1 ck0001496454 Operating Expenses Reimbursement Percentage Of Average Investment In Assets
OperatingExpensesReimbursementPercentageOfAverageInvestmentInAssets
0.02 pure
CY2013Q1 ck0001496454 Operating Expenses Reimbursement Percentage Of Net Income
OperatingExpensesReimbursementPercentageOfNetIncome
0.25 pure
CY2013Q1 ck0001496454 Construction Management Fees
ConstructionManagementFees
70000
CY2013Q1 ck0001496454 Construction Management Fee
ConstructionManagementFee
49009
CY2013Q1 ck0001496454 Distributions Received By Company
DistributionsReceivedByCompany
1517029
CY2013Q1 ck0001496454 Income Loss Allocable To Venture Partner Relating To Operations Of Properties
IncomeLossAllocableToVenturePartnerRelatingToOperationsOfProperties
-1193362
CY2013Q1 ck0001496454 Investment Services Fees
InvestmentServicesFees
1308116
CY2013Q1 ck0001496454 Lender Deposits
LenderDeposits
25000
CY2013Q1 ck0001496454 Loan Cost Amortization On Development Properties
LoanCostAmortizationOnDevelopmentProperties
56197
CY2013Q1 ck0001496454 Marketing Support Fees
MarketingSupportFees
2170882
CY2013Q1 ck0001496454 Selling Commissions
SellingCommissions
5041192
CY2013Q1 ck0001496454 Loan Costs Incurred Unpaid
LoanCostsIncurredUnpaid
121184
CY2013Q1 ck0001496454 Return Of Capital Dividends Percentage
ReturnOfCapitalDividendsPercentage
1.00 pure
CY2013Q1 ck0001496454 Stock Issuance And Other Offering Costs Incurred Unpaid
StockIssuanceAndOtherOfferingCostsIncurredUnpaid
344413
CY2013Q1 ck0001496454 Initial Public Offering Extension Period
InitialPublicOfferingExtensionPeriod
P180D
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
2680077
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1738562
CY2012Q1 us-gaap Asset Management Costs
AssetManagementCosts
70042
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27587629
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2413300
CY2012Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-844655
CY2012Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1922754
CY2012Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.3500 pure
CY2012Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
5642540
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
210196
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2012Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1899413
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1954009
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89300223
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83650000
CY2012Q1 ck0001496454 Business Acquisition Pro Forma Information Earnings Per Shares Basic And Diluted
BusinessAcquisitionProFormaInformationEarningsPerSharesBasicAndDiluted
-0.23
CY2012Q1 ck0001496454 Business Acquisition Pro Forma Weighted Average Number Basic And Diluted Shares Outstanding
BusinessAcquisitionProFormaWeightedAverageNumberBasicAndDilutedSharesOutstanding
3489867 shares
CY2012Q1 ck0001496454 Investment Services Fees
InvestmentServicesFees
1641345
CY2012Q1 ck0001496454 Marketing Support Fees
MarketingSupportFees
823472
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4886942
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
484048
CY2012Q1 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
1554925
CY2012Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
941515
CY2012Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
200000
CY2012Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
101
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86367290
CY2012Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
674839
CY2012Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
889949
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
385128
CY2012Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.3500 pure
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4044440
CY2012Q1 us-gaap Revenues
Revenues
941515
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7683
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2413300
CY2012Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
42
CY2012Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-792061
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2886564 shares
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2413300
CY2012Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
71400000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-674738
CY2012Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
844655
CY2012Q1 us-gaap Owned Property Management Costs
OwnedPropertyManagementCosts
16378
CY2012Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
90303
CY2012Q1 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
1789818
CY2012Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
7595647
CY2012Q1 ck0001496454 Offering Costs
OfferingCosts
1404690
CY2012Q1 ck0001496454 Fees And Commission Expenses
FeesAndCommissionExpenses
2744906
CY2012Q1 ck0001496454 Selling Commissions
SellingCommissions
1921434
CY2012Q1 ck0001496454 Return Of Capital Dividends Percentage
ReturnOfCapitalDividendsPercentage
1.00 pure
CY2012Q1 ck0001496454 Stock Issuance And Other Offering Costs Incurred Unpaid
StockIssuanceAndOtherOfferingCostsIncurredUnpaid
228738

Files In Submission

Name View Source Status
0001193125-13-219527-index-headers.html Edgar Link pending
0001193125-13-219527-index.html Edgar Link pending
0001193125-13-219527.txt Edgar Link pending
0001193125-13-219527-xbrl.zip Edgar Link pending
ck0001496454-20130331.xml Edgar Link completed
ck0001496454-20130331.xsd Edgar Link pending
ck0001496454-20130331_cal.xml Edgar Link unprocessable
ck0001496454-20130331_def.xml Edgar Link unprocessable
ck0001496454-20130331_lab.xml Edgar Link unprocessable
ck0001496454-20130331_pre.xml Edgar Link unprocessable
d516530d10q.htm Edgar Link pending
d516530dex311.htm Edgar Link pending
d516530dex312.htm Edgar Link pending
d516530dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending